BillionToOne Revenue and Competitors

Location

#2658

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • BillionToOne's estimated annual revenue is currently $98.7M per year.(i)
  • BillionToOne's estimated revenue per employee is $217,000
  • BillionToOne's total funding is $87.5M.

Employee Data

  • BillionToOne has 455 Employees.(i)
  • BillionToOne grew their employee count by 22% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.

keywords:N/A

$87.5M

Total Funding

455

Number of Employees

$98.7M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BillionToOne's People

NameTitleEmail/Phone
1
Regional Sales SpecialistReveal Email/Phone
2
VP, ReimbursementReveal Email/Phone
3
Regional Sales SpecialistReveal Email/Phone
4
Senior Billing SpecialistReveal Email/Phone
5
Senior Legal CounselReveal Email/Phone
6
Senior Client Services AssociateReveal Email/Phone
7
Senior Manager, Process EngineeringReveal Email/Phone
8
Senior Account ExecutiveReveal Email/Phone
9
Purchasing ManagerReveal Email/Phone
10
Senior Director, Market AccessReveal Email/Phone

BillionToOne News

2022-03-22 - BillionToOne Raises $125M to Expand Genetic Testing Platform

D., BillionToOne is a molecular diagnostics company with a mission to make molecular diagnostics more accurate, efficient, and accessible for...

2022-03-22 - BillionToOne raises $125m through Series C round

Molecular diagnostics firm BillionToOne has raised $125m through a Series C funding round to expand its commercial and clinical teams and...

2022-03-22 - BillionToOne Closes $125M Series C Funding with Premier ...

BillionToOne, headquartered in Menlo Park, California, is a molecular diagnostics company with a mission to make molecular diagnostics more...

2021-07-12 - BillionToOne Closes $55M Series B Funding

BillionToOne, Inc., a Menlo Park, Calif.-based molecular diagnostics company, closed a $55m Series B funding round. The round, announced in June 2021, was led by existing investor Hummingbird Ventures and incoming investor Four Rivers Group with participation from Neotribe Ventures, Norwest Ven ...

2020-03-10 - BillionToOne Closes $15M Follow-On Series A+ Funding Round

BillionToOne, Inc., a Menlo Park, Calif.-based precision diagnostics company that invented the patent-pending QCT™ molecular counter platform, closed its follow-on Series A+ funding round of $15m. The round was led by previous investors Hummingbird Ventures and NeoTribe Ventures with participat ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$76.4M463-4%$30.4M
#2
$123.6M47714%$87.9M
#3
$110.3M490N/AN/A
#4
$129.5M50029%$220M
#5
$91.2M513-5%$506.6M